Changing paradigms in bioequivalence trials submitted to the EMA for evaluation – A clinical and regulatory perspective by Nathaniel Refalo, Daniel Chetcuti, Amy Tanti, Anthony Serracino-Inglott, John Joseph Borg

Get full text